Microfluidic systems for modeling digestive cancer: a review of recent progress DOI

ZahraSadat Razavi,

M. Soltani, Hamidreza Pazoki–Toroudi

и другие.

Biomedical Physics & Engineering Express, Год журнала: 2024, Номер 10(5), С. 052002 - 052002

Опубликована: Авг. 14, 2024

Abstract Purpose . This review aims to highlight current improvements in microfluidic devices designed for digestive cancer simulation. The emphasizes the use of multicellular 3D tissue engineering models understand complicated biology tumor microenvironment (TME) and progression. purpose is develop oncology research improve patients’ lives. Methods analyzes recent on mimicking cancer. It uses tissue-engineered devices, notably organs a chip (OOC), simulate human organ function lab. Cell cultivation modern three-dimensional hydrogel platforms allows precise geometry, biological components, physiological qualities. novel methodologies, key findings, technical progress explain this field’s advances. Results study discusses advances Micro systems with are emphasized. These capture complex biochemical gradients, niche variables, dynamic cell–cell interactions (TME). reveal stomach progression by duplicating TME. Recent discoveries technology have improved our understanding gut biology, as shown review. Conclusion Microfluidic play crucial role modeling furthering research. could transform drug development treatment revealing provides complete summary suggests future field professionals. review’s major goal further medical

Язык: Английский

Normothermic liver machine perfusion as a dynamic platform for regenerative purposes: What does the future have in store for us? DOI Creative Commons
Bianca Lascaris, Vincent E. de Meijer, Robert J. Porte

и другие.

Journal of Hepatology, Год журнала: 2022, Номер 77(3), С. 825 - 836

Опубликована: Май 6, 2022

Язык: Английский

Процитировано

44

Global Literature Analysis of Organoid and Organ‐on‐Chip Research DOI Creative Commons
Jun‐ya Shoji, Richard P. Davis, Christine L. Mummery

и другие.

Advanced Healthcare Materials, Год журнала: 2023, Номер 13(21)

Опубликована: Июль 22, 2023

Organoids and cells in organ-on-chip platforms replicate higher-level anatomical, physiological, or pathological states of tissues organs. These technologies are widely regarded by academia, the pharmacological industry regulators as key biomedical developments. To map advances this emerging field, a literature analysis 16,000 article metadata based on quality-controlled text-mining algorithm is performed. The covers titles, keywords, abstracts categorized academic publications preprint databases published after 2010. identifies tracks 149 107 organs organ substructures modeled organoids organ-on-chip, respectively, stem cell sources, well 130 diseases, 16 groups organisms other than human mouse which organoid/organ-on-chip technology applied. illustrates changing diversity focus research captures its geographical distribution. downloadable dataset provided robust framework for researchers to interrogate with their own questions.

Язык: Английский

Процитировано

28

Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance DOI Open Access
Diego F. Calvisi, Luke Boulter, Javier Vaquero

и другие.

Nature Reviews Gastroenterology & Hepatology, Год журнала: 2023, Номер 20(7), С. 462 - 480

Опубликована: Фев. 8, 2023

Язык: Английский

Процитировано

23

Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development DOI Creative Commons

Dongxi Xiang,

Aina He, Rong Zhou

и другие.

Theranostics, Год журнала: 2024, Номер 14(8), С. 3300 - 3316

Опубликована: Янв. 1, 2024

Patient-derived organoids (PDOs) have emerged as a promising platform for clinical and translational studies. A strong correlation exists between outcomes the use of PDOs to predict efficacy chemotherapy and/or radiotherapy. To standardize interpretation enhance scientific communication in field cancer precision medicine, we revisit concept PDO-based drug sensitivity testing (DST). We present an expert consensus-driven approach medication selection aimed at predicting patient responses. further DST, propose guidelines clarification characterization. Additionally, identify several major challenges prediction when utilizing PDOs.

Язык: Английский

Процитировано

14

Microfluidic systems for modeling digestive cancer: a review of recent progress DOI

ZahraSadat Razavi,

M. Soltani, Hamidreza Pazoki–Toroudi

и другие.

Biomedical Physics & Engineering Express, Год журнала: 2024, Номер 10(5), С. 052002 - 052002

Опубликована: Авг. 14, 2024

Abstract Purpose . This review aims to highlight current improvements in microfluidic devices designed for digestive cancer simulation. The emphasizes the use of multicellular 3D tissue engineering models understand complicated biology tumor microenvironment (TME) and progression. purpose is develop oncology research improve patients’ lives. Methods analyzes recent on mimicking cancer. It uses tissue-engineered devices, notably organs a chip (OOC), simulate human organ function lab. Cell cultivation modern three-dimensional hydrogel platforms allows precise geometry, biological components, physiological qualities. novel methodologies, key findings, technical progress explain this field’s advances. Results study discusses advances Micro systems with are emphasized. These capture complex biochemical gradients, niche variables, dynamic cell–cell interactions (TME). reveal stomach progression by duplicating TME. Recent discoveries technology have improved our understanding gut biology, as shown review. Conclusion Microfluidic play crucial role modeling furthering research. could transform drug development treatment revealing provides complete summary suggests future field professionals. review’s major goal further medical

Язык: Английский

Процитировано

13